# Bilateral TAP and RS Blocks Using Liposomal Bupivacaine/Bupivacaine vs. Regular Bupivacaine in Laparoscopic Colectomy

> **NCT05224089** · PHASE4 · RECRUITING · sponsor: **Hartford Hospital** · enrollment: 114 (estimated)

## Conditions studied

- Bowel Disease

## Interventions

- **DRUG:** Liposomal Bupivicaine/Bupivacaine Admixture
- **DRUG:** Bupivacaine HCL

## Key facts

- **NCT ID:** NCT05224089
- **Lead sponsor:** Hartford Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-04-27
- **Primary completion:** 2025-11
- **Final completion:** 2026-02
- **Target enrollment:** 114 (ESTIMATED)
- **Last updated:** 2025-04-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05224089

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05224089, "Bilateral TAP and RS Blocks Using Liposomal Bupivacaine/Bupivacaine vs. Regular Bupivacaine in Laparoscopic Colectomy". Retrieved via AI Analytics 2026-07-27 from https://api.ai-analytics.org/clinical/NCT05224089. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*